Attached files
| file | filename |
|---|---|
| 8-K - PEAK PHARMACEUTICALS, INC. | peakpharmaform8kresignatione.htm |
![[form8kresignationeidebail001.jpg]](form8kresignationeidebail001.jpg)
Exhibit 16.1
July 15, 2016
Securities and Exchange Commission
100 F Street
Washington, DC 20549
Ladies and Gentlemen:
On July 12, 2016, we resigned as the independent registered public accounting firm for Peak Pharmaceuticals, Inc. (the Company).
We have read the Company’s disclosure set forth in Item 4.01, “Changes in Registrant’s Certifying Accountant” of the Company’s Current Report on Form 8-K dated July 15, 2016, and are in agreement with the disclosures in the Current Report, insofar as they pertain to our firm. We have not been requested to, nor are we providing any representations related to the other disclosures included in this Form 8-K.
Sincerely,
![[form8kresignationeidebail003.gif]](form8kresignationeidebail003.gif)
Eide Bailly LLP
www.eidebailly.com
800 Nicollet Mall, Ste. 1300 | Minneapolis, MN 55402-7033 | T 612.253.6500 | F 612.253.6600 | EOE